CN103224541A - 吉西他滨α-异构体转化回收工艺 - Google Patents
吉西他滨α-异构体转化回收工艺 Download PDFInfo
- Publication number
- CN103224541A CN103224541A CN2013101540074A CN201310154007A CN103224541A CN 103224541 A CN103224541 A CN 103224541A CN 2013101540074 A CN2013101540074 A CN 2013101540074A CN 201310154007 A CN201310154007 A CN 201310154007A CN 103224541 A CN103224541 A CN 103224541A
- Authority
- CN
- China
- Prior art keywords
- gemcitabine
- alpha
- isomer
- conversion
- tbah
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
转化量/mg | 转化收率/% | |
实施例一 | 5.6 | 49.2 |
实施例二 | 5.5 | 48.3 |
实施例三 | 5.0 | 43.9 |
实施例四 | 4.8 | 42.2 |
实施例五 | 4.5 | 39.5 |
实施例六 | 4.6 | 40.4 |
实施例七 | 5.0 | 43.9 |
对比例一 | 2.2 | 19.3 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310154007.4A CN103224541B (zh) | 2013-04-27 | 2013-04-27 | 吉西他滨α-异构体转化回收工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310154007.4A CN103224541B (zh) | 2013-04-27 | 2013-04-27 | 吉西他滨α-异构体转化回收工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103224541A true CN103224541A (zh) | 2013-07-31 |
CN103224541B CN103224541B (zh) | 2015-07-01 |
Family
ID=48835201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310154007.4A Active CN103224541B (zh) | 2013-04-27 | 2013-04-27 | 吉西他滨α-异构体转化回收工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103224541B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113583068A (zh) * | 2021-08-04 | 2021-11-02 | 上海兆维科技发展有限公司 | 一种利用强碱性阴离子交换树脂制备α-脱氧胞苷的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169728A (zh) * | 1994-12-13 | 1998-01-07 | 伊莱利利公司 | 1-(2'-脱氧-2',2'-二氟-d-呋喃核糖基)-4-氨基嘧啶-2-酮)盐酸盐的制备方法 |
WO2007049294A1 (en) * | 2005-10-28 | 2007-05-03 | Arch Pharmalabs Limited | An improved process for preparation of gemcitabine hydrochloride. |
CN101010329A (zh) * | 2004-12-30 | 2007-08-01 | 韩美药品株式会社 | 2’-脱氧-2’,2’-二氟胞苷的制备方法 |
CN101089010A (zh) * | 1998-02-25 | 2007-12-19 | 埃莫里大学 | 2'-氟代核苷 |
CN101381387A (zh) * | 2007-09-06 | 2009-03-11 | 上海迪塞诺医药发展有限公司 | 制备2’-脱氧-2’,2’-二氟-β-胞苷盐酸盐的方法 |
-
2013
- 2013-04-27 CN CN201310154007.4A patent/CN103224541B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169728A (zh) * | 1994-12-13 | 1998-01-07 | 伊莱利利公司 | 1-(2'-脱氧-2',2'-二氟-d-呋喃核糖基)-4-氨基嘧啶-2-酮)盐酸盐的制备方法 |
CN101089010A (zh) * | 1998-02-25 | 2007-12-19 | 埃莫里大学 | 2'-氟代核苷 |
CN101010329A (zh) * | 2004-12-30 | 2007-08-01 | 韩美药品株式会社 | 2’-脱氧-2’,2’-二氟胞苷的制备方法 |
WO2007049294A1 (en) * | 2005-10-28 | 2007-05-03 | Arch Pharmalabs Limited | An improved process for preparation of gemcitabine hydrochloride. |
CN101381387A (zh) * | 2007-09-06 | 2009-03-11 | 上海迪塞诺医药发展有限公司 | 制备2’-脱氧-2’,2’-二氟-β-胞苷盐酸盐的方法 |
Non-Patent Citations (2)
Title |
---|
万银波,等: "盐酸吉西他滨合成研究", 《精细化工中间体》 * |
姚博,等: "盐酸吉西他滨的合成路线图解", 《齐鲁药事》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113583068A (zh) * | 2021-08-04 | 2021-11-02 | 上海兆维科技发展有限公司 | 一种利用强碱性阴离子交换树脂制备α-脱氧胞苷的方法 |
CN113583068B (zh) * | 2021-08-04 | 2023-10-20 | 上海兆维科技发展有限公司 | 一种利用强碱性阴离子交换树脂制备α-脱氧胞苷的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103224541B (zh) | 2015-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016074736A5 (zh) | ||
JP2017522375A (ja) | 少なくとも1つのフェノール(または芳香族ヒドロキシル)基を含有する薬物分子に関する増大された生物学的利用能及びより低い必要用量のためのホウ素系プロドラッグ戦略 | |
RU2017119222A (ru) | Нейро-аттенуирующие кетаминовые и норкетаминовые соединения, их производные и способы их получения | |
NZ734152A (en) | Compounds, compositions and methods useful for cholesterol mobilisation | |
CN105906545B (zh) | 一种合成西他沙星中间体(7s)-5-氮杂螺[2.4]庚烷-7-基氨基甲酸叔丁酯的制备方法 | |
CN103224541B (zh) | 吉西他滨α-异构体转化回收工艺 | |
CN111217749A (zh) | 氘代喷他佐辛及制备方法、医药组合物和用途 | |
CN105085383A (zh) | 5-甲基-2(1h)吡啶酮衍生物及其制备方法和用途 | |
CN114716496B (zh) | 氟维司群衍生物及氟维司群衍生物制备方法和应用 | |
CN103755574A (zh) | 一种具有多光子吸收性质的三(9,9-二烷基-9h-芴基)胺的合成方法 | |
Kato et al. | Palladium (II) catalyzed carbonylative dimerization of allenyl ketones: efficient synthesis of difuranylketones | |
CN103086907A (zh) | 一种醋氯芬酸的制备方法 | |
CN109651377A (zh) | 一种治疗癌症的化合物及其用途 | |
Zhao et al. | Synthesis analogues of milbemycin and their bioactivity evaluation | |
CN1817868A (zh) | 一组抗厌氧菌感染的奥硝唑类衍生物及其制备方法 | |
CN101812071A (zh) | 硫酸氢氯吡格雷中间体拆分后的母液处理方法 | |
CN115160399B (zh) | 一种皂皮酸类化合物及其制备方法和医用用途 | |
CN101723959B (zh) | 头孢拉宗的精制方法 | |
CN102584737A (zh) | 抑制组蛋白去乙酰酶的物质的组成和使用 | |
Pelotte et al. | Design, synthesis, and characterization of 6β-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypes | |
CN108727351B (zh) | 一种普芦卡必利的精制方法 | |
Nguyen et al. | Using sodium dithionite as a reducing agent in the synthesis of propacetamol hydrochroride from phenol | |
CN105037314A (zh) | 多肟基柚皮素衍生物及其制备方法和应用 | |
CN106470682B (zh) | 2h-苯并吡喃衍生物作为镇痛药物的用途 | |
CN102702280B (zh) | 1,6-酐-2-叠氮-2-去氧-4-O-对甲氧苄基-β-D-吡喃葡萄糖苷的提纯方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee before: Jiangsu best Pharmaceutical Co.,Ltd. Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee after: Jiangsu best Pharmaceutical Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. |